These results weren\u2019t diagnostic of disease, but they painted a picture of a system under strain. And critically, they were modifiable.<\/p>\n\n\n\n
The subject began tracking sleep, activity, and recovery using the Ultrahuman Ring AIR. He also received personalized coaching and shifted his routine to include structured workouts, dietary adjustments, and improved sleep hygiene. <\/p>\n\n\n\n
Within weeks, the Ring AIR data started to show meaningful physiological changes. Sleep efficiency<\/strong> rose, resting heart rate<\/strong> during sleep declined, and heart rate variability <\/strong>increased. Recovery scores improved, and his movement patterns became more consistent.<\/p>\n\n\n\nA follow-up Blood Vision test in Week 7 confirmed that these changes weren\u2019t just surface-level. His HDL cholesterol rose, bringing his lipid profile closer to a healthier range. Fasting insulin levels dropped significantly, and HOMA-IR improved from 2.6 to 2.1, suggesting better glucose control and reduced insulin resistance. hsCRP levels also fell, pointing to a reduction in systemic inflammation.<\/p>\n\n\n\n
In short, the interventions had not only shifted daily wearable metrics but they had also altered underlying biological risk factors. What began as a proactive check-in had become a targeted course correction.<\/p>\n\n\n\n
Case 2: Wearable data revealing an underlying problem<\/h2>\n\n\n\n The second case followed a very different arc.<\/p>\n\n\n\n
A 43-year-old woman, a long-time Ultrahuman Ring AIR user, began noticing a creeping change in her data. Over several months, her resting heart rate<\/strong> rose steadily (5 bpm and night and 8 bpm during the day). Her recovery scores dropped<\/strong>, and despite maintaining a healthy lifestyle, her body felt less responsive. At the same time, she began experiencing excessive menstrual bleeding<\/strong>, which she initially chalked up to perimenopause.<\/p>\n\n\n\nWith no clear external explanation, she turned to Blood Vision, opting for a comprehensive panel with hormonal add-ons. The results brought clarity:<\/p>\n\n\n\n\nFerritin: 11.5 ng\/mL<\/strong> \u2014 Critically low iron stores, confirming iron-deficiency anemia.<\/li>\n\n\n\nHemoglobin: 10.2 g\/dL<\/strong> \u2014 Below the threshold for clinical anemia in women.<\/li>\n\n\n\nhsCRP: 11.846 mg\/L & ESR: 69 mm\/hr<\/strong> \u2014 Strongly elevated inflammatory markers.<\/li>\n\n\n\nFree T4: 2.34 ng\/dL<\/strong> \u2014 Slightly raised thyroid hormone, sometimes seen during hormonal transitions.<\/li>\n\n\n\nNLR: 3.2<\/strong> \u2014 Marginally above normal, reinforcing the inflammation signal.These results pointed to a system under physiological stress, likely driven by ongoing blood loss. She consulted her physician and gynecologist, and a follow-up ultrasound confirmed the presence of a previously undiagnosed uterine fibroid \u2013 a direct explanation for the anemia and inflammation.<\/p>\n\n\n\n
She began treatment that included iron supplementation (ferrous fumarate), anti-inflammatory support (glutathione and selenium), and medication (tranexamic acid) to reduce bleeding. <\/p>\n\n\n\n
Notably, many of these interventions aligned with recommendations already surfaced in her UltraTrace report, suggesting glutathione, boron, selenium, and creatine supplementation<\/p>\n\n\n\n
Over the next 12 weeks, her Ring AIR metrics began to return to baseline. Resting heart rates declined<\/strong>, and recovery scores stabilized<\/strong>. The data reflected a reversal of the deterioration trend that had prompted testing in the first place.<\/p>\n\n\n\nWithout the Ultrahuman Ring AIR signal, this condition could have been missed or diagnosed much later.<\/p>\n\n\n\n
![\"Case](\"https:\/\/blog.ultrahuman.com\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-15-at-11.26.57.png\")
<\/figure>\n\n\n\n![\"Case](\"https:\/\/blog.ultrahuman.com\/wp-content\/uploads\/2025\/07\/Screenshot-2025-07-15-at-11.26.44-1024x524.png\")
<\/figure>\n\n\n\n![\"Action](\"https:\/\/blog.ultrahuman.com\/wp-content\/uploads\/2023\/12\/Action-Plan-1024x576.png\")
<\/figure>\n\n\n\n